Infection Prevention and Control Measures for Marburg Virus Disease
Share this article
How Marburg Virus Spreads
Marburg virus is transmitted to humans through contact with infected fruit bats—the reservoir host of the virus—or infected non-human primates.
Subsequent person-to-person spread occurs through direct contact with blood or bodily fluids of an infected individual or contact with contaminated fomites or surfaces. Transmission can also occur from exposure to semen of men who have recovered from Marburg virus disease (MVD).
Health care personnel can reduce the risk of Marburg virus disease (MVD) transmission by correctly and consistently implementing infection control measures.
Ensure Early Isolation Through the Identify, Isolate, and Inform Framework
Use the “Identify, Isolate, and Inform” strategy to ensure individuals at risk for MVD are identified and isolated appropriately, and communication is expedited.
- Identify patients by assessing the potential for exposure; this can include a travel history to an outbreak area in the past 21 days with relevant exposures, as well as signs or symptoms (CDC, https://www.cdc.gov/marburg/about/index.html#cdc_disease_basics_symptoms-symptoms, Accessed 3/3/2023) matching those of MVD within the correct time frame.
- If the patient reports possible exposure to Marburg virus AND exhibits signs or symptoms of MVD, isolate them in a private (single occupancy) room with a dedicated bathroom or a covered, bedside commode.
- Inform your facility’s Infection Prevention and Control Program and involved health care personnel about the suspected case; they will often support communication with local or state health departments to determine next steps, such as arranging for testing.
In the early stages, MVD can be difficult to distinguish from other infectious diseases that might be the cause of symptoms in a returning traveler. HCP should also consider malaria, typhoid fever, dengue, or other viral hemorrhagic fevers that may be present in the area where the patient has traveled, such as Lassa fever or Ebola virus disease.
Isolation Precautions and Personal Protective Equipment (PPE)
The patient should be placed in a private (single occupancy) room with a private bathroom or a covered, bedside commode. The door should be kept closed. Avoid aerosol-generating procedures (AGPs), if possible. Any necessary AGPs should be performed in an airborne infection isolation room (AIIR).
Follow the CDC’s recommendations (CDC, https://www.cdc.gov/vhf/ebola/healthcare-us/ppe/guidance.html, Accessed 3/3/2023) for PPE, which includes PPE that fully covers skin and clothing and prevents any exposure of the eyes, nose, and mouth to reduce the risk of accidental self-contamination of mucous membranes or broken skin.
Fully body coverage is used for patients who are “wet,” a term used to indicate patients who are diaphoretic, vomiting, bleeding, or having diarrhea. Patients who are clinically stable and do not have bleeding, vomiting, or diarrhea are considered “dry.”
| Personal Protective Equipment | Clinically Stable or “Dry” Patient | Clinically Unstable or “Wet” Patient |
| Gown or Coverall | Fluid-resistant gown extending to mid-calf or coverall without integrated hood | Impermeable coverall or gown extending to mid-calf |
| Respiratory, Head, and Face Protection | Full-face shield and face mask | PAPR or NIOSH-certified N95 respirator; if a N95 respirator is used, add a surgical hood extending to shoulders and a full-face shield |
| Boot or Shoe Covers | N/A | Covers that extend to at least mid-calf |
| Gloves | Two pairs of gloves; at minimum, the outer pair should have extended cuffs | Two pairs of gloves; at minimum, the outer pair should have extended cuffs |
| Apron | N/A | Apron donned over the gown or coverall that covers the torso to mid-calf if the coverall has an exposed zipper on the front or for the care of patients with vomiting and/or diarrhea |
Refer to the CDC’s Personal Protective Equipment (PPE) Training (CDC, https://www.cdc.gov/viral-hemorrhagic-fevers/hcp/guidance/index.html, Accessed 3/3/2023) for information on the safe donning and doffing of PPE.
Cleaning and Disinfection
The CDC’s Cleaning and Disinfecting (CDC, https://www.cdc.gov/vhf/ebola/clinicians/cleaning/hospitals.html, Accessed 3/3/2023) guidance for Ebola virus disease also applies to MVD. Key points include:
- Use single-use medical equipment when available. If reusable equipment must be used, clean and disinfect it according to the Spaulding Classification scheme (CDC, https://www.cdc.gov/infectioncontrol/guidelines/disinfection/rational-approach.html, Accessed 3/3/2023).
- Clean and disinfect environmental surfaces at regular intervals. For disinfection, use a U.S. Environmental Protection Agency (EPA)-registered hospital disinfectant with efficacy against enveloped viruses, such as sodium hypochlorite (bleach) or quaternary ammonium.
- Refer to the EPA’s List L: Disinfectants for Use Against Ebola Virus (EPA, https://www.epa.gov/pesticide-registration/epas-registered-antimicrobial-products-effective-against-ebola-virus-list-l, Accessed 3/3/2023) and List Q: Disinfectants for Emerging Viral Pathogens (EVPs) (EPA, https://www.epa.gov/pesticide-registration/disinfectants-emerging-viral-pathogens-evps-list-q, Accessed 3/3/2023) for additional guidance on choosing a suitable disinfectant.
Waste Management
Patients with MVD can produce large amounts of infectious waste.
Marburg virus is a Category A infectious substance; NETEC’s Category A Waste Management Tips for Ebola Virus Disease provides guidance for waste management that also applies to managing waste generated by a patient with MVD.
Other Important Infection Prevention and Control Practices
- Perform frequent hand hygiene
- Avoid entry of visitors into the patient’s room (except on a case-by-case basis when essential for the patient’s wellbeing)
- Limit the number of health care personnel who provide care for suspected and confirmed cases
- Maintain a log of all people who enter the patient’s room
- Develop a plan to manage HCP should they be exposed to blood or bodily fluids from a suspected or confirmed case
- Minimize the use of needles and other sharps
- When performing aerosol-generating procedures:
- Only essential personnel should be present.
- All staff should be wearing appropriate PPE, including respiratory protection, as described above.
- Use an airborne infection isolation room (AIIR) when AGPS are anticipated or planned. Minimize entry and exit during the procedure and shortly afterward.
Additional Resources
- Centers for Disease Control and Prevention – Infection Prevention and Control Recommendations for Hospitalized Patients Under Investigation (PUIs) for Ebola Virus Disease (EVD) in U.S. Hospitals (CDC, https://www.cdc.gov/vhf/ebola/clinicians/evd/infection-control.html, Accessed 3/3/2023)
- PPE Matrix for High-Consequence Infectious Diseases
- Public Health Management of People with Suspected or Confirmed VHFs or High-risk Exposures (CDC, https://www.cdc.gov/viral-hemorrhagic-fevers/php/public-health-strategy/people-with-suspected-or-confirmed-vhf-or-high-risk.html, Accessed 3/3/2023)
- Managing Solid Waste Contaminated with a Category A Infectious Substance (DOT, https://www.phmsa.dot.gov/transporting-infectious-substances/planning-guidance-handling-category-solid-waste, Updated 2024)
- PPE Breaches: Understanding the Risks and How to Respond
About the Authors
Justin Chan, MD, MPH, is an infectious disease physician with the NYC Health + Hospital/Bellevue Regional Emerging Special Pathogen Treatment Center (RESPTC) and serves as the System Chief Hospital Epidemiologist for NYC Health + Hospitals. He is an Assistant Professor of Medicine at NYU Grossman School of Medicine in the Division of Infectious Diseases & Immunology.
Katherine Gaddis, RN, is a public health nurse in Upstate New York and a graduate student in the University of Nebraska Medical Center (UNMC)’s online MPH-Epidemiology program. She is interested in emerging infectious diseases, infection prevention and control, and outbreak investigations. In addition to her professional interests, Katherine enjoys spending time with her family, traveling, and reading. Katherine is currently a student worker at NETEC.
Erica S. Shenoy, MD, PhD, is an infectious diseases physician at the Massachusetts General Hospital, where she is the associate chief of the Infection Control Unit and medical director of the Regional Emerging Special Pathogens Treatment Center (RESPTC). She is an associate professor at Harvard Medical School.